• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911416350
Device Problem Occlusion Within Device (1423)
Patient Problems Angina (1710); Dyspnea (1816); Fatigue (1849); Reocclusion (1985); Pain (1994); Weakness (2145)
Event Date 09/27/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.The device was not returned for analysis.A review of the manufacturing documentation found that all devices shipped from the batch conformed to the preventive measures / current controls as per product specification.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Event Description
It was reported that the patient experienced cardiac angina and in-stent restenosis occurred.In (b)(6) 2013, the patient presented due to unstable angina.Subsequently, the index procedure and coronary angiography were performed.The target lesion was a de novo lesion located in the mid right coronary artery (rca) with 99% stenosis and was 12mm long with a reference vessel diameter of 3.75mm.The target lesion was treated with pre-dilatation and placement of a 3.50x16mm promus element¿ plus drug-eluting stent.Following post dilatation residual stenosis was 0%.On the following day, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2017, the patient came for a follow-up visit for chronic coronary disease and severe dyslipoproteinemia.The patient had a generalized fatigue, weakness, shortness of breath and pain in her upper arms.The patient was treated with medication in response to the event.The patient was referred for cardiac catheterization due to chest pain, dyspnea and positive stress test.The 99% stenosis from mid rca to distal rca was treated with placement of 3.00 x 32mm synergy stent with 0% residual stenosis.On the same day, the event was considered as resolved.In (b)(6) 2017, the patient was diagnosed with cardiac angina.Subsequently, the patient was treated with stent to left circumflex (lcx) artery.On the same day, outcome of the event was considered as resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6957035
MDR Text Key89564491
Report Number2134265-2017-10283
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 09/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/17/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/09/2013
Device Model NumberH7493911416350
Device Catalogue Number39114-1635
Device Lot Number15474826
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/29/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/05/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age79 YR
-
-